These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2519124)

  • 21. Low-dose captopril alone and in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension.
    Pandhi P; Mondal S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):294-7. PubMed ID: 3525427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and diagnostic evaluation of the treatment of systemic arterial hypertension with captopril and hydrochlorothiazide].
    Caporicci D; Achilli L; Pepi R; Mori A
    Clin Ter; 1985 Apr; 113(2):105-10. PubMed ID: 3893866
    [No Abstract]   [Full Text] [Related]  

  • 23. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diuretic-resistant hypertension. Effect of an additional daily single dose of a ACE inhibitor].
    Baumgart P; Tenschert W; Vetter H
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1832-4. PubMed ID: 3003892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.
    Bénétos A; Laflèche A; Asmar R; Gautier S; Safar A; Safar ME
    J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antihypertensive effects of captopril, hydrochlorothiazide, alone or in combination, with different categories of essential hypertensive patients].
    Senn N; Ollivier JP; Abitbol JP; Garay R
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():155-8. PubMed ID: 3142400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Captopril in mild or moderate systemic arterial hypertension].
    Spritzer N; Wolmeister H; Spritzer TS; Maciel R
    Arq Bras Cardiol; 1984 Jun; 42(6):447-50. PubMed ID: 6393923
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating black hypertensives with capozide.
    Katz LA; Cobbol C
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):224S-226S. PubMed ID: 3046629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of captopril, metoprolol and hydrochlorothiazide therapy in patients with non-insulin-dependent diabetes (NIDDM) and primary hypertension. A double-blind, randomized cross-over study].
    Gall MA; Rossing P; Skøtt P; Hommel EE; Mathiesen ER; Gerdes LU; Lauritzen M; Vølund A; Faergeman O; Beck-Nielsen H
    Ugeskr Laeger; 1993 Mar; 155(9):636-41. PubMed ID: 8447032
    [No Abstract]   [Full Text] [Related]  

  • 32. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
    Cheung DG; Gasster JL; Weber MA
    Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multicenter study of the efficacy of 3 antihypertensive regimens: captopril + hydrochlorothiazide, oxprenolol + hydrochlorothiazide, and alphamethyldopa + hydrochlorothiazide].
    Ocón J; Oliván J; Garrido Peralta M; Ruilope L; Rodicio JL; Seco Vasco J; Rodríguez Alvarez J; Gras X
    Med Clin (Barc); 1985 Nov; 85(15):617-21. PubMed ID: 3908851
    [No Abstract]   [Full Text] [Related]  

  • 35. [Captopril and hydrochlorothiazide combined in the treatment of mild-to-moderate hypertension. Evaluation of sugar and lipid metabolism in a long-term study].
    Malacco E; Magenta M; Noia E; Renesto E; Sartini C; Botta GF
    Minerva Med; 1989 Oct; 80(10):1115-8. PubMed ID: 2682377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Report on treatment with captopril and hydrochlorothiazide combination. Comprehensive therapy of hypertension].
    Fortschr Med Suppl; 1990; 101():1-15. PubMed ID: 2227755
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of mild and moderate hypertension with the use of captopril alone or combined with hydrochlorothiazide. A multicenter study].
    Nascimento LO; Lion R; Lion MF; Pesquisadores E
    Arq Bras Cardiol; 1989 Sep; 53(3):177-83. PubMed ID: 2698133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of essential arterial hypertension in the elderly with low-dose captopril and hydrochlorothiazide. Long-term study].
    Aranda-Lara P; Gras-Balaguer X; Cabello M; Martín-Reyes G; Valera A; Frutos M; López de Novales E
    Rev Clin Esp; 1987 Sep; 181(4):185-9. PubMed ID: 3313556
    [No Abstract]   [Full Text] [Related]  

  • 39. [Assessment of tolerability and antihypertensive efficacy of aceplus mite (captopril (CPT) 50 mg + hydrochlorothiazide (HCTZ) 15 mg): a double-blind study vs. HCTZ in diabetic hypertensive patients. A report on three treatments].
    Santucci A; De Cesaris R; Buoninconti R; Botta GF
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):149-53. PubMed ID: 2678308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations.
    Rolland PH; Friggi A; Barlatier A; Piquet P; Latrille V; Faye MM; Guillou J; Charpiot P; Bodard H; Ghiringhelli O
    Circulation; 1995 Feb; 91(4):1161-74. PubMed ID: 7850955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.